| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| Anson Funds Management LP | 7 | 7 | 0.01% | 0.05% | 0.16% | Q4 2016 | Q2 2018 | 7 |
| SABBY MANAGEMENT, LLC | 7 | 7 | 0.00% | 0.00% | 0.01% | Q4 2016 | Q2 2018 | 7 |
| UBS Group AG | 5 | 2 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q3 2018 | 7 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 5 | 5 | 0.00% | 0.00% | 0.00% | Q4 2016 | Q4 2017 | 5 |
| Citadel Advisors | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2018 | Q3 2018 | 1 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2018 | Q3 2018 | 1 |
| Virtu KCG Holdings LLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2017 | Q2 2017 | 1 |
External links
This page lists all the filers that currently own IMMUNOCELLULAR THERAPEUTICS or have owned IMMUNOCELLULAR THERAPEUTICS in the past.